Compare Bandwidth Inc (BAND) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bandwidth Inc vs BIO-TECHNE Corp — how do they compare? Bandwidth Inc trades at $51.52 (market cap $1.70B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 6.6× Bandwidth Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Bandwidth Inc pays none. Which is the better fit depends on your goals.
| BAND | TECH | |
|---|---|---|
Market Cap | $1.70B | $11.24B |
Sector | Technology | Health |
52-Week High | $78.44 | $72.29 |
52-Week Low | $12.82 | $43.31 |
Enterprise Value | $2.08B | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bandwidth (BAND) trades at $49.96, up 11.79% in 24 hours, with bullish technical signals and strong analyst support. Recent Q2 2026 earnings beat estimates, driven by AI-driven communications demand, with revenue up 22% year-over-year. The company raised its 2026 outlook, reflecting operational momentum and margin expansion.
Outlook is positive with a $75.25 consensus price target, though risks include thin net margins and high valuation multiples. Growth hinges on AI adoption and enterprise wins, but competitive pressures and execution challenges remain key watchpoints for investors.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bandwidth Inc
Bandwidth is a global communications software company. Its CPaaS platform allows enterprises to embed voice, messaging, and 911 emergency services directly into their software applications via robust APIs.
Read more on BAND →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
